36 completed, 21 unknown, 6 terminated, 4 withdrawn. 67 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 67 | Completed 36, Unknown 21, Terminated 6, Withdrawn 4 |
Follow Covid19: new trials by email Literature Review of Covid19 trials Research Report on Covid19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium Valproate, Quetiapine, Standard of Care - Covid19, Hyperactive Delirium | Phase 4 | Withdrawn | University of Miami | 2023-03-28 | 2023-03-31 | |
| Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19 Carrageenan nasal spray and 1% PVP- mouthwash and gargle - Covid19, SARS-CoV 2 Infection | Phase 4 | Completed | National Taiwan University Hospital | 7 | 2022-06-24 | 2023-08-15 |
| SOLIDARITY Finland Plus Long-COVID Imatinib, Infliximab - Covid19, Coronavirus Disease 2019 | Phase 4 | Unknown | Clinical Urology and Epidemiology Working Group | 400 | 2022-02-06 | 2022-05-03 |
| RECOVAC Repeated Vaccination Study mRNA-1273, Ad26.COV2.S vaccine - Covid19, Kidney Diseases | Phase 4 | Completed | University Medical Center Groningen | 336 | 2021-10-21 | 2022-03-29 |
| Factors Influencing the COVID-19 Vaccine Immune Response According to Age and Presence or Not of a Past History of COVID-19 COVID-19 vaccine Pfizer (3 doses), COVID-19 vaccine Pfizer (2 doses), COVID-19 mRNA Vaccine Moderna (3 doses) - Covid19 | Phase 4 | Completed | Centre Hospitalier Universitaire de Saint Etienne | 54 | 2021-10-05 | 2024-12-11 |
| Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Niagen - Covid19, Sequelae of; Infection | Phase 4 | Completed | Massachusetts General Hospital | 72 | 2021-08-28 | 2025-08-05 |
| Vaccination for Recovered Inpatients With COVID-19 (VATICO) Moderna mRNA-1273 COVID-19 vaccine, Pfizer BNT162b2 COVID-19 vaccine - Covid19 | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 66 | 2021-08-25 | 2024-03-27 |
| Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19 standard treatment COVID-19 + Triazavirin - Covid19 | Phase 4 | Unknown | Ain Shams University | 80 | 2021-08-01 | 2021-07-22 |
| Cetirizine and Famotidine for COVID-19 Cetirizine and Famotidine, Placebo - Covid19 | Phase 4 | Withdrawn | Emory University | 2021-08-01 | 2021-08-20 | |
| Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease cholecalciferol 6 lakh IU - Covid19 | Phase 4 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 90 | 2021-08-01 | 2021-12-21 |
| SOLIDARITY Finland Long-COVID (Remdesivir Long-term Follow-up Study of COVID Patients) Remdesivir - Covid19 | Phase 4 | Unknown | Clinical Urology and Epidemiology Working Group | 202 | 2021-07-24 | 2022-07-15 |
| Evaluation of Aerosol in a Dental Clinic High volume evacuation (HVE), Extraoral vacuum aspirator (EVA), Hydrogen Peroxide - Covid19 | Phase 4 | Completed | The University of Texas Health Science Center, Houston | 41 | 2021-07-21 | 2025-07-08 |
| Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California COVID-19 Individual Awareness and Education., COVID-19 Community Outreach & Health Promotion., COVID-19 Individual Health Education & Linkages to Medical and Supportive Services. - Vaccine Refusal, Covid19 | Phase 4 | Completed | Britt Skaathun | 1051 | 2021-07-16 | 2025-06-06 |
| SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine Study-provided Moderna mRNA-1273 COVID-19 vaccine, Community-provided Moderna mRNA-1273 COVID-19 Vaccine, Community-Provided Pfizer-BioNTech BNT162b2 COVID-19 Vaccine - Covid19, SARS-CoV2 Infection | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 43 | 2021-07-09 | 2023-05-24 |
| Remdesivir- Ivermectin Combination Therapy in Severe Covid-19 Ivermectin - Covid19 | Phase 4 | Unknown | Assiut University | 60 | 2021-07-01 | 2021-06-29 |
| Echinacea Drug for Covid-19 Equinacea Arkopharma, Placebo - Covid19 | Phase 4 | Unknown | Jesús R. Requena | 230 | 2021-06-18 | 2021-08-10 |
| Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients mRNA-1273 vaccine, Normal Saline Placebo - Vaccine Response Impaired, Immune Suppression | Phase 4 | Completed | University Health Network, Toronto | 120 | 2021-05-25 | 2022-08-02 |
| Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease Methylprednisolone Tablet - Covid19, COVID-19 Pneumonia | Phase 4 | Completed | Turkish Thoracic Society | 262 | 2021-05-24 | 2023-10-10 |
| COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine immunogenicity after first and second dose - Covid19 | Phase 4 | Completed | Sciensano | 145 | 2021-05-10 | 2023-03-28 |
| Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19) Famotidine 20 milligram tablet - Covid19 | Phase 4 | Withdrawn | drpykessupplements.com | 2021-05-01 | 2021-12-20 |
Showing 20 of 67. Sign in to see all of them.
COVID-19 (67) · Coronavirus Infections (5) · Anosmia (3) · Post-Acute COVID-19 Syndrome (3) · Pneumonia (2) · Pneumonia, Viral (2) · Respiratory Tract Infections (2) · Severe Acute Respiratory Syndrome (2) · Acquired Immunodeficiency Syndrome (1) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Coronaviridae Infections (1) · Cough (1) · Cross Infection (1) · Diabetes Mellitus, Type 2 (1)
Lung Diseases (67) · Respiratory Tract Diseases (67) · Coronaviridae Infections (66) · Infections (66) · Nidovirales Infections (66) · RNA Virus Infections (66) · Virus Diseases (66) · Pneumonia (65) · Pneumonia, Viral (65) · Respiratory Tract Infections (65) · Coronavirus Infections (62) · Pathological Conditions, Signs and Symptoms (8) · Nervous System Diseases (5) · Pathologic Processes (5) · Disease Attributes (4)
Dexamethasone (7) · Ivermectin (5) · Standard of Care (5) · 2019-nCoV Vaccine mRNA-1273 (3) · BNT162 Vaccine (3) · Heparin (3) · Hydroxychloroquine (3) · Sodium Chloride (3) · Vaccines (3) · bamlanivimab (3) · remdesivir (3) · Enoxaparin (2) · Famotidine (2) · Hydrogen Peroxide (2) · Lopinavir (2)
ClinAmygate (4) · China National Biotec Group Company Limited (2) · Clinical Urology and Epidemiology Working Group (2) · FMH College of Medicine and Dentistry (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Ahmed Essam (1) · Ain Shams University (1) · Alexandria University (1) · Ariel Dogliotti (1) · Assiut University (1) · Brazilian Clinical Research Institute (1) · Britt Skaathun (1) · Brno University Hospital (1) · Bryn Mawr Hospital (1) · Butantan Institute (1)
United States (17) · Egypt (9) · Brazil (4) · Spain (4) · Argentina (3) · Canada (3) · Italy (3) · Netherlands (3) · Belgium (2) · China (2) · Czechia (2) · Finland (2) · India (2) · Pakistan (2) · France (1)
Aijaz Zeeshan Khan Chachar, MBBS,FCPS (2) · Emad R Issak, MD (2) · Kari AO Tikkinen, MD PhD (2) · Alain Tremblay (1) · Argentina E Servin, MD,MPH (1) · Christine Stabell Benn, Professor (1) · Claudia Ruiz Brisuela, DDS (1) · Dan Griffin, MD, PHD (1) · David Smith, MD, MAS (1) · David T Huang, MD, MPH (1) · Deepali Kumar, MD (1) · Divisha Sharma, MD (1) · Dominique L Musselman, MD (1)
PMID 34473343, PMID 11225528, PMID 11505791, PMID 16444180, PMID 16490989, PMID 17099299, PMID 20354090, PMID 23017003, PMID 23433693, PMID 29633177, PMID 30639191, PMID 31761015, PMID 32047895, PMID 32159775, PMID 32326426, PMID 32425001, PMID 32505069, PMID 32517353, PMID 32641154, PMID 32859459, PMID 33215159, PMID 33397432, PMID 33502773, PMID 33538761, PMID 33585031, PMID 33648568, PMID 33757717, PMID 34034784, PMID 34037911, PMID 34044151, PMID 34493311, PMID 34629893, PMID 34645381, PMID 34658014, PMID 34764044, PMID 34807716, PMID 34916266, PMID 35033182, PMID 35075450, PMID 35135470, PMID 35244208, PMID 35697146, PMID 35713300, PMID 35788169, PMID 35834252, PMID 35931636, PMID 36062970, PMID 36190994, PMID 36354032, PMID 36695483
1OT2HL156812-01 (1), R01MD016872 (1)